Joddes Limited

Joddes Limited

Founded in 1974 as the investment arm for pharmacist-entrepreneur Morris Goodman, Joddes Limited stewards the capital generated by the global success of Pharmascience, the generic drug manufacturer Goodman co-founded. The Goodman family's wealth is now interfaced with the office through the next generation: sons David and Jonathan Goodman, who lead Pharmascience and Knight Therapeutics respectively, with family matriarch Rosalind Goodman holding philanthropic influence through the family foundation. Joddes's investment posture leans into direct real estate, buyouts, and secondaries, with a footprint that spans Canada, the United States, and South Africa. The office holds domestic Quebec industrial and commercial assets, including the Pharmascience distribution centre in Dorval and the corporate headquarters on Royalmount Avenue, alongside a land parcel in Stowe, Vermont. Across the Atlantic, the office has held a stake in Firefly Investments Ltd., a commercial property vehicle in Johannesburg. The strategy favors concentrated, long-duration bets rather than spray-and-pray fund commitments, a style consistent with single-family offices that prioritize control and alignment over blind-pool fees. The office operates with a lean team led by President and CEO Marc Rouleau, who previously served as President of the Montreal Bond Traders Association and maintains ties to the Canadian institutional network through AIMA Canada membership. The family's broader ecosystem includes the Morris & Rosalind Goodman Family Foundation, chaired by Shawna Goodman Sone, which operates as a distinct philanthropic vehicle. The multi-generational governance structure — with next-gen family members running the operating companies and a non-family executive managing the office — creates a clean separation between wealth creation and wealth stewardship, a model that allocators recognize as durable. Joddes's architecture as a non-family-led office managing single-family capital is its defining structural feature. While the Goodman family retains ownership and board-level influence, the day-to-day investment decisions sit with a professional executive, a governance choice that reduces the key-person risk endemic to patriarch-led family offices. This alignment of professional management with patient, multi-generational capital allows the office to compete for deals that require stable, non-institutional timelines, a posture increasingly valuable in private markets.